tirzepatide and nafld Synergistic mechanisms of low-energy ketogenic therapy Tirzepatide: Effective for Fatty Liver

Immunolocalization of pro- and mature-brain derived neurotrophic factor (BDNF) and receptor TrkB in the human brainstem and hippocampus

Covarrubias G, Moon TJ, Loutrianakis G, Sims HM, Umapathy MP, Lorkowski ME, et al

Tirzepatide is FDA-approved (for diabetes and weight loss, depending on the brand) and works as a dual-agonist, targeting GLP-1 and GIP receptors to reduce appetite, improve insulin response, and support weight loss

Wu J, Li Z, Yang Z, Guo L, Zhang Y, Deng H, et al

1 It is characterized by a steatotic liver with one or more cardiometabolic risk factors, in the absence of excessive alcohol consumption

The patient improved with the above measures